SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-031046
Filing Date
2018-05-08
Accepted
2018-05-08 06:03:30
Documents
45
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a18-8625_110q.htm 10-Q 470543
2 EX-31.1 a18-8625_1ex31d1.htm EX-31.1 13675
3 EX-31.2 a18-8625_1ex31d2.htm EX-31.2 13663
4 EX-32.1 a18-8625_1ex32d1.htm EX-32.1 8168
  Complete submission text file 0001104659-18-031046.txt   2658156

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mdgl-20180331.xml EX-101.INS 542099
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mdgl-20180331.xsd EX-101.SCH 26132
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mdgl-20180331_cal.xml EX-101.CAL 26870
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mdgl-20180331_def.xml EX-101.DEF 88472
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT mdgl-20180331_lab.xml EX-101.LAB 242384
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mdgl-20180331_pre.xml EX-101.PRE 176893
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 18812839
SIC: 2834 Pharmaceutical Preparations